ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

Funding Opportunities

September 27, 2002

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979